Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...ld standard in tracking and reporting global funding for neglected disease R&D. This year’s report, the sixteenth overall, focuses on investments made in participants’ 2022 financial year (‘FY2022’) and, for the first time, adds comprehensive coverage of the product pipeline in each disease area.
more
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
Updated version June 2015
F1000Research 2019, 8:323 Last updated: 17 MAY 2019